{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:42:17Z","timestamp":1790505737382,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10-11","license":[{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"crossref","award":["2108085QH309"],"award-info":[{"award-number":["2108085QH309"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Postgraduate Research Projects of Universities in Anhui Province","award":["YJS20210293"],"award-info":[{"award-number":["YJS20210293"]}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81700522"],"award-info":[{"award-number":["81700522"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00011-022-01617-8","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T18:02:48Z","timestamp":1659808968000},"page":"1283-1303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["RNF2 mediates pulmonary fibroblasts activation and proliferation by regulating mTOR and p16-CDK4-Rb1 signaling pathway"],"prefix":"10.1007","volume":"71","author":[{"given":"Linxin","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanrong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,6]]},"reference":[{"issue":"10082","key":"1617_CR1","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","volume":"389","author":"L Richeldi","year":"2017","unstructured":"Richeldi L, Collard HR, Jones MG, et al. Idiopathic PF. Lancet. 2017;389(10082):1941\u201352.","journal-title":"Lancet"},{"issue":"3","key":"1617_CR2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1183\/09031936.00185114","volume":"46","author":"J Hutchinson","year":"2015","unstructured":"Hutchinson J, Fogarty A, Hubbard R, et al. Global incidence and mortality of idiopathic PF: a systematic review. Eur Respir J. 2015;46(3):795\u2013806.","journal-title":"Eur Respir J"},{"issue":"5","key":"1617_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S2213-2600(20)30062-X","volume":"8","author":"M Wijsenbeek","year":"2020","unstructured":"Wijsenbeek M. Progress in the treatment of PF. Lancet Respir Med. 2020;8(5):424\u20135.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"1617_CR4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ymthe.2019.11.027","volume":"28","author":"M Bisserier","year":"2020","unstructured":"Bisserier M, Milara J, Abdeldjebbar Y, et al. AAV1.SERCA2a Gene Therapy Reverses PF by Blocking the STAT3\/FOXM1 Pathway and Promoting the SNON\/SKI Axis. Mol Ther. 2020;28(2):394\u2013410.","journal-title":"Mol Ther"},{"key":"1617_CR5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.omtm.2021.01.003","volume":"20","author":"MJR Ruigrok","year":"2021","unstructured":"Ruigrok MJR, Frijlink HW, Melgert BN, et al. Gene therapy strategies for idiopathic PF: recent advances, current challenges, and future directions. Mol Ther Methods Clin Dev. 2021;20:483\u201396.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"1","key":"1617_CR6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.semarthrit.2020.12.003","volume":"51","author":"B Wu","year":"2021","unstructured":"Wu B, Tang L, Kapoor M. Fibroblasts and their responses to chronic injury in PF. Semin Arthritis Rheum. 2021;51(1):310\u20137.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"1617_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/mi.2008.85","volume":"2","author":"MS Wilson","year":"2009","unstructured":"Wilson MS, Wynn TA. PF: pathogenesis, etiology and regulation. Mucosal Immunol. 2009;2(2):103\u201321.","journal-title":"Mucosal Immunol"},{"issue":"1","key":"1617_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12931-018-0730-2","volume":"19","author":"G Sgalla","year":"2018","unstructured":"Sgalla G, Iovene B, Calvello M, et al. Idiopathic PF: pathogenesis and management. Respir Res. 2018;19(1):32.","journal-title":"Respir Res"},{"issue":"Pt 2","key":"1617_CR9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1042\/BJ20041982","volume":"389","author":"SJ Lee","year":"2005","unstructured":"Lee SJ, Choi D, Rhim H, et al. E3 ubiquitin ligase RNF2 interacts with the S6\u2019 proteasomal ATPase subunit and increases the ATP hydrolysis activity of S6\u2019. Biochem J. 2005;389(Pt 2):457\u201363.","journal-title":"Biochem J"},{"issue":"12","key":"1617_CR10","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1158\/2159-8290.CD-15-0493","volume":"5","author":"K Rai","year":"2015","unstructured":"Rai K, Akdemir KC, Kwong LN, et al. Dual roles of RNF2 in melanoma progression. Cancer Discov. 2015;5(12):1314\u201327.","journal-title":"Cancer Discov"},{"issue":"3","key":"1617_CR11","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.18632\/oncotarget.14142","volume":"8","author":"M Wei","year":"2017","unstructured":"Wei M, Jiao D, Han D, et al. Knockdown of RNF2 induces cell cycle arrest and apoptosis in prostate cancer cells through the upregulation of TXNIP. Oncotarget. 2017;8(3):5323\u201338.","journal-title":"Oncotarget"},{"issue":"8","key":"1617_CR12","doi-asserted-by":"publisher","first-page":"5453","DOI":"10.1002\/jcp.30260","volume":"236","author":"Q Yan","year":"2021","unstructured":"Yan Q, Chen BJ, Hu S, et al. Emerging role of RNF2 in cancer: from bench to bedside. J Cell Physiol. 2021;236(8):5453\u201365.","journal-title":"J Cell Physiol"},{"issue":"12","key":"1617_CR13","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1038\/sj.onc.1210806","volume":"27","author":"D Choi","year":"2008","unstructured":"Choi D, Lee SJ, Hong S, et al. Prohibitin interacts with RNF2 and regulates E2F1 function via dual pathways. Oncogene. 2008;27(12):1716\u201325.","journal-title":"Oncogene"},{"issue":"5","key":"1617_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1139\/bcb-2018-0252","volume":"97","author":"J Yang","year":"2019","unstructured":"Yang J, Yu F, Guan J, et al. Knockdown of RNF2 enhances the radiosensitivity of squamous cell carcinoma in lung. Biochem Cell Biol. 2019;97(5):589\u201399.","journal-title":"Biochem Cell Biol"},{"issue":"11","key":"1617_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s12032-016-0835-8","volume":"33","author":"GE Carpagnano","year":"2016","unstructured":"Carpagnano GE, Lacedonia D, Soccio P, et al. How strong is the association between IPF and lung cancer? An answer from airway\u2019s DNA. Med Oncol. 2016;33(11):119.","journal-title":"Med Oncol"},{"issue":"2","key":"1617_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.chest.2019.04.114","volume":"156","author":"A Tzouvelekis","year":"2019","unstructured":"Tzouvelekis A, Gomatou G, Bouros E, et al. Common pathogenic mechanisms between idiopathic pf and lung cancer. Chest. 2019;156(2):383\u201391.","journal-title":"Chest"},{"issue":"9","key":"1617_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138625","volume":"10","author":"YS Gui","year":"2015","unstructured":"Gui YS, Wang L, Tian X, et al. mTOR overactivation and compromised autophagy in the pathogenesis of PF. PLoS ONE. 2015;10(9): e0138625.","journal-title":"PLoS ONE"},{"issue":"4","key":"1617_CR18","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.bbrc.2018.04.148","volume":"500","author":"Q Han","year":"2018","unstructured":"Han Q, Lin L, Zhao B, et al. Inhibition of mTOR ameliorates bleomycin-induced PF by regulating epithelial-mesenchymal transition. Biochem Biophys Res Commun. 2018;500(4):839\u201345.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1617_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1530\/ERC-19-0011","volume":"26","author":"K Wong","year":"2019","unstructured":"Wong K, Di Cristofano F, Ranieri M, et al. PI3K\/mTOR inhibition potentiates and extends palbociclib activity in anaplastic thyroid cancer. Endocr Relat Cancer. 2019;26(4):425\u201336.","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"1617_CR20","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.3390\/ijms19113611","volume":"19","author":"A Saito","year":"2018","unstructured":"Saito A, Horie M, Micke P, et al. The Role of TGF-\u03b2 signaling in lung cancer associated with idiopathic PF. Int J Mol Sci. 2018;19(11):3611.","journal-title":"Int J Mol Sci"},{"key":"1617_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.lfs.2019.05.052","volume":"230","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Jiao H, Wu Y, et al. P120-catenin regulates PF and TGF-\u03b2 induced lung fibroblast differentiation. Life Sci. 2019;230:35\u201344.","journal-title":"Life Sci"},{"key":"1617_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","volume":"97","author":"AD Theocharis","year":"2016","unstructured":"Theocharis AD, Skandalis SS, Gialeli C, et al. Extracellular matrix structure. Adv Drug Deliv Rev. 2016;97:4\u201327.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"1617_CR23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.yexmp.2015.01.006","volume":"98","author":"NU Hansen","year":"2015","unstructured":"Hansen NU, Genovese F, Leeming DJ, et al. The importance of extracellular matrix for cell function and in vivo likeness. Exp Mol Pathol. 2015;98(2):286\u201394.","journal-title":"Exp Mol Pathol"},{"issue":"148","key":"1617_CR24","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0033-2018","volume":"27","author":"C Upagupta","year":"2018","unstructured":"Upagupta C, Shimbori C, Alsilmi R, et al. Matrix abnormalities in PF. Eur Respir Rev. 2018;27(148): 180033.","journal-title":"Eur Respir Rev"},{"issue":"24","key":"1617_CR25","doi-asserted-by":"publisher","first-page":"9739","DOI":"10.3390\/ijms21249739","volume":"21","author":"GA Cabral-Pacheco","year":"2020","unstructured":"Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C, et al. The roles of matrix metalloproteinases and their inhibitors in human diseases. Int J Mol Sci. 2020;21(24):9739.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1617_CR26","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s10753-018-0742-6","volume":"41","author":"L Wu","year":"2018","unstructured":"Wu L, Luo Z, Zheng J, et al. IL-33 can promote the process of pf by inducing the imbalance between MMP-9 and TIMP-1. Inflammation. 2018;41(3):878\u201385.","journal-title":"Inflammation"},{"issue":"40","key":"1617_CR27","doi-asserted-by":"publisher","first-page":"16420","DOI":"10.1074\/jbc.M117.805747","volume":"292","author":"C Huang","year":"2017","unstructured":"Huang C, Xiao X, Yang Y, et al. MicroRNA-101 attenuates PF by inhibiting fibroblast proliferation and activation. J Biol Chem. 2017;292(40):16420\u201339.","journal-title":"J Biol Chem"},{"issue":"2","key":"1617_CR28","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/toxsci\/kfz103","volume":"170","author":"KM Hanson","year":"2019","unstructured":"Hanson KM, Hernady EB, Reed CK, et al. Apoptosis resistance in fibroblasts precedes progressive scarring in pf and is partially mediated by toll-like receptor 4 activation. Toxicol Sci. 2019;170(2):489\u201398.","journal-title":"Toxicol Sci"},{"key":"1617_CR29","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/978-981-15-4272-5_40","volume":"1207","author":"X Lv","year":"2020","unstructured":"Lv X, Li K, Hu Z. Autophagy and PF. Adv Exp Med Biol. 2020;1207:569\u201379.","journal-title":"Adv Exp Med Biol"},{"issue":"17","key":"1617_CR30","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1242\/dev.137075","volume":"143","author":"JS Yu","year":"2016","unstructured":"Yu JS, Cui W. Proliferation, survival and metabolism: the role of PI3K\/AKT\/mTOR signalling in pluripotency and cell fate determination. Development. 2016;143(17):3050\u201360.","journal-title":"Development"},{"issue":"3","key":"1617_CR31","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","volume":"101","author":"A Szwed","year":"2021","unstructured":"Szwed A, Kim E, Jacinto E. Regulation and metabolic functions of mTORC1 and mTORC2. Physiol Rev. 2021;101(3):1371\u2013426.","journal-title":"Physiol Rev"},{"key":"1617_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2018.04.041","volume":"429","author":"CK Huang","year":"2018","unstructured":"Huang CK, Iwagami Y, Zou J, et al. Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation. Cancer Lett. 2018;429:1\u201310.","journal-title":"Cancer Lett"},{"issue":"6","key":"1617_CR33","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1593\/neo.12656","volume":"14","author":"HS Cho","year":"2012","unstructured":"Cho HS, Hayami S, Toyokawa G, et al. RB1 methylation by SMYD2 enhances cell cycle progression through an increase of RB1 phosphorylation. Neoplasia. 2012;14(6):476\u201386.","journal-title":"Neoplasia"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-022-01617-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-022-01617-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-022-01617-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T04:19:56Z","timestamp":1666930796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-022-01617-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,6]]},"references-count":33,"journal-issue":{"issue":"10-11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1617"],"URL":"https:\/\/doi.org\/10.1007\/s00011-022-01617-8","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,6]]},"assertion":[{"value":"16 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declared that there is no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}